The Liability of Drug Analysis from the Story of Intravenous Iodine-Contained Contrast Medium

DSpace/Manakin Repository

dc.contributor.advisor	Hutt, Peter Barton	en_US
dc.contributor.author	Huang, Chun-Ming	en_US
dc.date.accessioned	2012-06-07T02:59:56Z
dc.date.issued	1999	en_US
dc.identifier.citation	The Liability of Drug Analysis from the Story of Intravenous Iodine-Contained Contrast Medium (1999 Third Year Paper)	en
dc.identifier.uri	http://nrs.harvard.edu/urn-3:HUL.InstRepos:8846755
dc.description.abstract	The development of the liability of drugs is a complicated and sophisticated process, like the development of drugs. Intravenous iodine-contained contrast medium, a diagnostic drug with excellent effectiveness and unavoidable risks, shows the controversial characteristics in the development of drug liability and administrative regulation.	en
dc.language.iso	en_US	en
dash.license	LAA	en_US
dc.subject	Food and Drug Law	en
dc.subject	liability	en
dc.subject	drug	en
dc.subject	regulation	en
dc.subject	FDA	en
dc.subject	intravenous iodine-contained contrast medium	en
dc.title	The Liability of Drug Analysis from the Story of Intravenous Iodine-Contained Contrast Medium	en
dc.type	Paper (for course/seminar/workshop)	en_US
dc.date.available	2012-06-07T02:59:56Z